Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 18, 2025
Transactions
19
Purchases
0
Sales
19
Purchase value
$0.00
Sale value
$60.75M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
Beth Ann CostelloEVP and CFO
4Rule 10b5-1 plan disclosed
Filed Nov 4, 2026Period of report Nov 2, 20260001225208-26-008664
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 2, 2026
Common StockF1
31,597
$135.75
$4.29M
82,988.282
Direct
Filing footnotes · 10
F1The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Ms. Costello on July 28, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F10One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
F2The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
F3The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
F4The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
F5The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
F6The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
F7The options became fully exercisable on February 28, 2026, the third anniversary of the grant date.
F8One-third of the options became exercisable on February 27, 2025, an additional one-third of the options became exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
F9One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
Filed May 29, 2026Period of report May 27, 20260001225208-26-005642
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 27, 2026
Common StockF1
8,895
$135.13
$1.20M
38,208.27
Direct
Filing footnotes · 10
F1The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F10One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
F2The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
F3The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
F4The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
F5The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
F6The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
F7The options became fully exercisable on February 28, 2026, the third anniversary of the grant date.
F8One-third of the options became exercisable on February 27, 2025, an additional one-third of the options became exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
F9One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
Filed Mar 12, 2026Period of report Mar 10, 20260001225208-26-003580
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 10, 2026
Common StockF1
10,500
$138.0613
$1.45M
55,584.617
Direct
SaleMar 10, 2026
Common StockF2
30,193
$138.0417
$4.17M
25,391.617
Direct
Filing footnotes · 7
F1Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $138.06 - $138.10 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $137.98 - $138.22 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
F4The options became fully exercisable on February 28, 2026, the third anniversary of the grant date.
F5One-third of the options became exercisable on February 27, 2025, an additional one-third of the options became exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
F6One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
F7One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
Filed Mar 5, 2026Period of report Mar 4, 20260001225208-26-003270
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 4, 2026
Common Stock
701.584
$140.515
$98.58K
622.156
Direct
Filing footnotes · 1
F1This figure represents the reporting person's approximate share equivalent holdings in The Hartford Stock Fund (the "Fund") under the Company's 401(k) plan. The Fund consists of Company common stock (typically 99% of the Fund value) and short-term investments (typically less than 1% of the Fund value) and the number of share equivalents varies depending on the performance of the Company, the overall stock market, the amount of cash awaiting investment, and the performance and amount of short-term investments held by the Fund, less any expense accrued against the Fund. The number of shares attributed to the reporting person and expressed as share equivalents is based on information furnished by the 401(k) plan administrator as of March 4, 2026.
Filed Feb 27, 2026Period of report Feb 26, 20260001225208-26-002753
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 26, 2026
Common StockF1
374.915
$141.9695
$53.23K
622.156
Direct
Filing footnotes · 2
F1Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $141.79 - $141.97 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2This figure represents the reporting person's approximate share equivalent holdings in The Hartford Stock Fund (the "Fund") under the Company's 401(k) plan. The Fund consists of Company common stock (typically 99% of the Fund value) and short-term investments (typically less than 1% of the Fund value) and the number of share equivalents varies depending on the performance of the Company, the overall stock market, the amount of cash awaiting investment, and the performance and amount of short-term investments held by the Fund, less any expense accrued against the Fund. The number of shares attributed to the reporting person and expressed as share equivalents is based on information furnished by the 401(k) plan administrator as of February 26, 2026.
Filed Feb 26, 2026Period of report Feb 24, 20260001225208-26-002682
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 25, 2026
Common StockF1
8,307
$140.54
$1.17M
38,208.27
Direct
Filing footnotes · 10
F1The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F10One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
F2One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
F3The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
F4The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
F5The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
F6The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
F7The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
F8One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
F9One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
Filed Feb 13, 2026Period of report Feb 11, 20260001225208-26-001845
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 11, 2026
Common StockF1
5,681
$141.8277
$805.72K
18,399.962
Direct
Filing footnotes · 6
F1Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $141.81 - $141.87 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
F3The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
F4One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
F5One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
F6One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
Filed Feb 6, 2026Period of report Feb 4, 20260001225208-26-001422
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 4, 2026
Common StockF1F2
19,778
$141.1913
$2.79M
276,008.948
Direct
SaleFeb 4, 2026
Common StockF1F3
81,192
$140.6763
$11.42M
194,816.948
Direct
Filing footnotes · 12
F1The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on November 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2017 and are scheduled to expire on February 28, 2027.
F10One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
F11One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
F12One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
F2Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $141 - $141.47 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $140 - $140.99 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.
F5The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
F6The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
F7The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
F8The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
F9The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
Filed Feb 4, 2026Period of report Feb 2, 20260001225208-26-001301
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 2, 2026
Common StockF1F2
7,598
$137.0759
$1.04M
389,156.948
Direct
SaleFeb 2, 2026
Common StockF1F3
7,845
$137.0851
$1.08M
381,311.948
Direct
SaleFeb 2, 2026
Common StockF1F4
19,734
$135.5357
$2.67M
361,577.948
Direct
SaleFeb 2, 2026
Common StockF1F5
19,834
$135.5629
$2.69M
341,743.948
Direct
SaleFeb 2, 2026
Common StockF1F6
73,390
$136.5725
$10.02M
268,353.948
Direct
SaleFeb 2, 2026
Common StockF1F6
73,537
$136.5779
$10.04M
194,816.948
Direct
Filing footnotes · 15
F1The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on November 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2017 and are scheduled to expire on February 28, 2027.
F10The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
F11The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
F12The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
F13One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
F14One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
F15One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
F2Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $137.04 - $137.14 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $137.04 - $137.13 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $135.04 - $135.89 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $135.04 - $135.93 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $136.04 - $137.03 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.
F8The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
F9The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
Filed Jan 6, 2026Period of report Jan 2, 20260001225208-26-000337
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 2, 2026
Common StockF1F2
11,368
$137.037
$1.56M
101,544.606
Direct
SaleJan 2, 2026
Common StockF1F3
23,971
$136.3704
$3.27M
77,573.606
Direct
Filing footnotes · 12
F1The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Ms. Costello on August 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F10One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
F11One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
F12One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
F2Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $136.90 - $137.19 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $135.90 - $136.90 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.
F5The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
F6The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
F7The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
F8The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
F9The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
Filed Dec 1, 2025Period of report Nov 26, 20250001225208-25-009499
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 26, 2025
Common StockF1
6,731
$137.90
$928.20K
31,721.067
Direct
Filing footnotes · 10
F1The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F10One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
F2The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.
F3The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
F4The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
F5The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
F6The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
F7The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
F8One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
F9One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.